Login / Signup

Differences in the placebo response in duloxetine and venlafaxine trials.

Johanna BreilmannToshiaki A FurawakaThomas BeckerMarkus Kösters
Published in: Acta psychiatrica Scandinavica (2018)
Our analyses show a significant difference in the placebo response between venlafaxine and duloxetine trials and suggest that the investigated drug has an influence on the placebo response that is not related to baseline severity, changes over the years or other variables we included.
Keyphrases
  • double blind
  • phase iii
  • clinical trial
  • emergency department